The purpose of this study is to evaluate the safety of an investigational drug in subjects with COPD. The study will involve up to 6 study visits and last approximately 12 months. Eligible participants must meet the following criteria:
If you are interested in participating in this study please fill out this pre-screening form and someone from our staff will contact you regarding your qualifications for the study.